Germing U - Search Results

1

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.

de Swart L, Smith A, Johnston TW, Haase D, Droste J, Fenaux P, Symeonidis A, Sanz G, Hellström-Lindberg E, Cermák J, Germing U, Stauder R, Georgescu O, MacKenzie M, Malcovati L, Holm MS, Almeida AM, Mądry K, Slama B, Guerci-Bresler A, Sanhes L, Beyne-Rauzy O, Luño E, Bowen D, de Witte T. de Swart L, et al. Among authors: germing u. Br J Haematol. 2015 Aug;170(3):372-83. doi: 10.1111/bjh.13450. Epub 2015 Apr 24. Br J Haematol. 2015. PMID: 25907546 Clinical Trial.

2

[Myelodysplastic syndromes. The epidemiological and etiological aspects].

Aul C, Gattermann N, Germing U, Runde V, Heyll A. Aul C, et al. Among authors: germing u. Dtsch Med Wochenschr. 1992 Aug 14;117(33):1223-31. doi: 10.1055/s-2008-1062434. Dtsch Med Wochenschr. 1992. PMID: 1499520 German.

3

Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1992 Jan;6(1):52-9. Leukemia. 1992. PMID: 1736014

4

Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.

Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1994 Nov;8(11):1906-13. Leukemia. 1994. PMID: 7967735

5

Serum deoxythymidine kinase in myelodysplastic syndromes.

Aul C, Gattermann N, Germing U, Winkelmann M, Heyll A, Runde V, Schneider W. Aul C, et al. Among authors: germing u. Cancer. 1994 Jan 15;73(2):322-7. doi: 10.1002/1097-0142(19940115)73:2<322::aid-cncr2820730215>3.0.co;2-e. Cancer. 1994. PMID: 8293395

6

Increasing incidence of myelodysplastic syndromes: real or fictitious?

Aul C, Germing U, Gattermann N, Minning H. Aul C, et al. Among authors: germing u. Leuk Res. 1998 Jan;22(1):93-100. doi: 10.1016/s0145-2126(97)00089-1. Leuk Res. 1998. PMID: 9585086

7

[Role of aggressive treatment strategies for myelodysplastic syndromes].

Aul C, Germing U, Minning H, Kobbe G, Gattermann N, Südhoff T, Meckenstock G, Söhngen D, Heyll A. Aul C, et al. Among authors: germing u. Praxis (Bern 1994). 1999 Mar 4;88(10):431-8. Praxis (Bern 1994). 1999. PMID: 10199215 Review. German.

8

Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction.

Germing U, Gattermann N, Aivado M, Hildebrandt B, Aul C. Germing U, et al. Br J Haematol. 2000 Mar;108(4):724-8. doi: 10.1046/j.1365-2141.2000.01940.x. Br J Haematol. 2000. PMID: 10792275

9

Long-term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesis.

Aivado M, Rong A, Germing U, Gattermann N, Kobbe G, Rieth C, Haas R, Aul C. Aivado M, et al. Among authors: germing u. Br J Haematol. 2000 Sep;110(4):884-6. doi: 10.1046/j.1365-2141.2000.02302.x. Br J Haematol. 2000. PMID: 11054075

10

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients.

Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Germing U, et al. Leuk Res. 2000 Dec;24(12):983-92. doi: 10.1016/s0145-2126(00)00088-6. Leuk Res. 2000. PMID: 11077111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

453 results

Search Page

Filters